logo
AAT Bioquest

Histone-lysine N-methyltransferase SETD7 Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
3-[3-[4-[4-(Trifluoromethyl)phenyl]-1H-indole-1-yl]benzylamino]benzoic acidIC509930.0 [1], 19000.0 [2], 19500.0 [3], 22500.0 [4]
CyproheptadineIC501000.0 [1], 3400.0 [2], 20000.0 [3]
CyproheptadineKi15000.0 [1]
S-Adenosyl-L-homocysteineIC5030000.0 [1]
SinefunginIC502500.0 [1]
CID 71268957IC5063000.0 [1]
CID 46901937IC5040000.0 [1]
PimethixeneIC504300.0 [1]
CID 71300326IC502.0 [1]
CID 44251522IC5040000.0 [1]
CID 53315882IC5010000.0 [1]
6,7-Dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amineIC50100000.0 [1]
N-(3-Nitrophenyl)-1,3-benzodioxole-5-carboxamideIC5061750.0 [1]
CID 16451230IC50150000.0 [1]
Ethyl 2-amino-4-methyl-5-[(3-nitrophenyl)carbamoyl]thiophene-3-carboxylateIC504590.0 [1]
1-Methyl-4-xanthen-9-ylidene-piperidineIC5016300.0 [1]
4-Fluoren-9-ylidene-1-methyl-piperidineIC5041500.0 [1]
1-Methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)piperidineIC5059100.0 [1]
Methyl 2-amino-4-methyl-5-[(3-nitrophenyl)carbamoyl]thiophene-3-carboxylateIC504880.0 [1]
1-Methyl-4-(9h-xanthen-9-yl)piperazineIC50100000.0 [1]
Carm1-IN-1IC50667000.0 [1]
Piperidine, 4-(diphenylmethylene)-1-methyl-IC5094600.0 [1]
PRMT5 Inhibitor C17IC50100000.0 [1]
(2S)-2-Amino-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]-N-[(3-phenyl-1H-pyrazol-5-yl)methyl]butanamideIC50100000.0 [1]
5-Methyl-N-(3-nitrophenyl)furan-3-carboxamideIC5089180.0 [1]
2-Amino-4-methyl-5-(3-nitroanilinocarbonyl)thiophene-3-carboxylic acid isobutyl esterIC5037670.0 [1]
Carbamoyl 2-amino-4-methyl-5-[(3-nitrophenyl)carbamoyl]thiophene-3-carboxylateIC5049520.0 [1]
Ethyl 2-amino-5-[(3-cyanophenyl)carbamoyl]-4-methylthiophene-3-carboxylateIC5061550.0 [1]
1-Methyl-4-(9H-thioxanthen-9-yl)piperazineIC50100000.0 [1]
1-Methyl-4-(9H-xanthen-9-yloxy)piperidineIC50100000.0 [1]
1-Methyl-4-(9H-thioxanthen-9-yloxy)piperidineIC50100000.0 [1]
1-Methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyloxy)piperidineIC50100000.0 [1]
4-Methyl-3-nitro-N-(3-nitrophenyl)benzamideIC50189700.0 [1]
1-Ethyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidineIC507200.0 [1]
1-Methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)piperazineIC50100000.0 [1]
1-Hexyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidineIC5042000.0 [1]
N-[(2-Methoxyphenyl)methyl]-2-[3-[[2-(methylamino)ethylamino]methyl]phenyl]-5-(trifluoromethyl)pyrazole-3-carboxamideIC50100000.0 [1]
2-[5-[[[(2S)-2-Aminopropanoyl]amino]methyl]thiophen-3-yl]-N-[(2-methoxyphenyl)methyl]-5-(trifluoromethyl)pyrazole-3-carboxamideIC50100000.0 [1]
Cyproheptadine M (nor), acetylatedIC50100000.0 [1]
(3E,5E)-3,5-Bis[(3-bromo-4-hydroxyphenyl)methylidene]-1-[(3-chlorophenyl)methyl]piperidin-4-oneIC50174000.0 [1]
(3E,5E)-3,5-Bis[(3-bromo-4-hydroxyphenyl)methylidene]-1-phenacylpiperidin-4-oneIC50149000.0 [1]
(3E,5E)-3,5-Bis[(3-bromo-4-hydroxyphenyl)methylidene]-1-[(2-methylphenyl)methyl]piperidin-4-oneIC50667000.0 [1]
(3E,5E)-3,5-Bis[(3-bromo-4-hydroxyphenyl)methylidene]-1-[(3-methylphenyl)methyl]piperidin-4-oneIC50667000.0 [1]
(3E,5E)-3,5-Bis[(3-bromo-4-hydroxyphenyl)methylidene]-1-[(4-methylphenyl)methyl]piperidin-4-oneIC50333000.0 [1]
(3E,5E)-3,5-Bis[(3-bromo-4-hydroxyphenyl)methylidene]-1-[(2-chlorophenyl)methyl]piperidin-4-oneIC50667000.0 [1]
(3E,5E)-3,5-Bis[(3-bromo-4-hydroxyphenyl)methylidene]-1-[(4-chlorophenyl)methyl]piperidin-4-oneIC50600000.0 [1]
(3E,5E)-3,5-Bis[(3-bromo-4-hydroxyphenyl)methylidene]-1-(2-phenylethyl)piperidin-4-oneIC50667000.0 [1]
(3E,5E)-3,5-Bis[(3-bromo-4-hydroxyphenyl)methylidene]-1-(3-phenylpropyl)piperidin-4-oneIC50667000.0 [1]
N-[(6-Methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-6-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1-propan-2-ylindazole-4-carboxamideIC5049000.0 [1]
N-[4-(4-Aminophenyl)sulfonylphenyl]-4-phenylbenzamideIC5066400.0 [1]
(2S,5S)-2-Amino-6-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]-5-(propylamino)hexanoic acidIC502200.0 [1]
N-[(4,6-Dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1-propan-2-ylindazole-4-carboxamideIC50214000.0 [1]
N-(3,4-Dimethoxyphenyl)-3-nitrobenzamideIC5030040.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Histone-lysine N-methyltransferase SETD7 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.20 Nov2024https://www.aatbio.com/data-sets/histone-lysine-n-methyltransferase-setd7-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 20). Quest Database™ Histone-lysine N-methyltransferase SETD7 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/histone-lysine-n-methyltransferase-setd7-inhibitors-ic50-ki.
BibTeXEndNoteRefMan